Due to recent changes in the official account push mechanism, we welcome you to set Boom Health as a "starred" account on the official account homepage to get the latest trends and expert insights in the digital healthcare industry第一时间!
01 Global Digital Health Investment and Financing OverviewFabric, a nursing support platform, secures $60 million in Series A fundingOn February 21, Fabric, a nursing support platform, secured $60 million in Series A funding. This round was led by General Catalyst, with continued participation from Thrive Capital, GV, and other prominent investors. The funds will be used to advance Fabric's mission of humanizing healthcare through the automation of administrative and clinical tasks, thereby empowering both patients and clinicians.AI Digital Twin Platform Unlearn.AI Secures $50 Million in Series C FundingOn February 9, AI digital twin platform Unlearn.AI secured $50 million in Series C funding, led by Altimeter Capital. The company plans to use these funds to advance artificial intelligence by investing in its people, data, engineering capabilities, and long-term R&D initiatives, eliminating trial and error in the medical field.Oula Health Completes $28 Million Series B FinancingOn February 20, Oula, a provider of comprehensive prenatal care services, completed a $28 million Series B financing round, co-led by Revolution Ventures and Maverick Ventures. The company plans to use the funds to expand its technology-supported hybrid care approach to more markets beyond New York and to launch new services for women of childbearing age.Upwards, a provider of home care solutions, raises $21 million in Series B fundingOn February 15, Upwards, a provider of home care solutions, secured $21 million in Series B funding, led by Alpha Edison with participation from M13 and Fika Ventures. The company plans to use the funds to accelerate expansion and enhance customer experience for families, caregivers, as well as new and existing employer and government partners.Computer-Aided Surgery Solution Provider Pixee Medical Secures $15 Million in FinancingOn February 8, Pixee Medical, a provider of computer-assisted surgical solutions, raised $15 million in funding led by Relyens Innovation Santé, UI Investissement, InnoVacom, Angelor, and Bpifrance. The new round of financing will enable Pixee Medical to accelerate its development in the United States and launch the next generation of innovative products.Clinical Trial Information Platform Power Raises $11.9 Million in Series A FundingOn February 21, clinical trial information platform Power secured $11.9 million in Series A funding, led by Kin, Contrary, and Footwork. The new round of financing provides momentum for Power's mission to democratize clinical trials and diversify participants, ultimately accelerating life-saving medical research.Virtual Diabetes Clinic 9am.health Raises $9.5 Million in Series A FundingOn February 19, virtual diabetes clinic 9am.health secured $9.5 million in Series A funding. The round was led by Cigna Ventures, with additional support from existing institutional investors including 7Wire Ventures, Define Ventures, Leaps by Bayer, and Founders Fund. The company plans to use the new funds to expand its services, enhance patient experience, and strengthen its team.Health Monitoring Platform Lilli Secures £8.2 Million in Series A FundingOn February 8, Lilli, a health monitoring platform, secured £8.2 million in Series A funding, led by West Hill Capital. The funds will be used for commercial expansion and artificial intelligence development. Lilli provides non-invasive, round-the-clock behavioral monitoring, enabling early detection of changes and reducing hospitalizations, bringing the benefits of remote monitoring to more people, supporting independent living, and alleviating the burden on the healthcare sector.Anatomy Financial, a Medical Financial Operations Automation Platform, Raises $7.6 Million in New FundingOn February 13, Anatomy Financial, a medical financial operations automation platform, secured $7.6 million in new funding from investors including Lightspeed, Meridian Street Capital, Live Oak Ventures, Cambrian Ventures, and Peterson Ventures. The new funding will be used to build a healthcare financial operating system.Dina, a care coordination platform, raises $7 million in Series B fundingOn February 16, Dina, a care coordination platform, secured $7 million in Series B funding, led by venture capital firm First Analysis. SCAN Group also invested in Dina in 2023 as part of its mission to enhance healthcare for the elderly. Dina will use this investment to support its go-to-market strategy and product roadmap.AI Medical Insurance Claims Platform MediConCen Raises $6.85 Million in Series A FundingOn February 12, AI health insurance claims platform MediConCen secured a $6.85 million Series A funding round. This round was led by HSBC Asset Management. The funds will be used to drive the company's expansion into international markets such as the Middle East and Southeast Asia. The company has obtained blockchain technology patents in the United States and Hong Kong, serving 16 insurance companies and over one million policyholders.AI Speech Rehabilitation Company Altavo Completes €5 Million Series A FinancingOn February 20, Altavo, an AI-powered voice rehabilitation company, completed a €5 million Series A financing round. This round was led by Occident, with participation from Novalis Biotech, Beteiligungsmanagement Thüringen, TGFS Technologiegründerfonds Sachsen, High-Tech Gründerfonds, Saxonia Systems Holding, and TUDAG TU Dresden AG. The company plans to use the funds to accelerate development, product innovation, key clinical trials, and international expansion.Virtual Reality Medical Platform Avatar Medical Secures €5M in Seed FundingOn February 19, virtual reality medical platform Avatar Medical secured €5 million in seed funding. The round was led by GO Capital, with participation from Acorn Pacific Ventures, Plug and Play, Rives Croissance, and Cenitz. The company plans to use the funds for commercialization investments in the United States and Europe, while accelerating the development of its AvatarCloud product.02 Digital Health Industry Dynamics
Astellas Collaborates with Kelonia TherapeuticsOn February 15, Astellas announced that its wholly-owned subsidiary Xyphos Biosciences and Kelonia Therapeutics have reached a research collaboration and licensing agreement to jointly develop novel cancer immunotherapies. The two parties will combine Kelonia's iGPS® platform with Xyphos' ACCEL TM technology to develop two innovative in vivo CAR-T cell therapies.VantAI Announces Strategic Collaboration with Bristol-Myers SquibbOn February 13, VantAI announced a strategic partnership with Bristol-Myers Squibb to jointly discover new molecular glues for certain therapeutic targets. This collaboration leverages VantAI's geometric deep learning capabilities and Bristol-Myers Squibb’s expertise in targeted protein degradation to discover and develop new small-molecule therapies. Under the agreement, VantAI is eligible to receive up to $674 million from Bristol-Myers Squibb in discovery, development, clinical, regulatory, and sales milestone payments, with the option to expand into additional therapeutic programs.BioNTech and Autolus Therapeutics Announce Strategic CollaborationOn February 12, BioNTech and Autolus Therapeutics announced a strategic collaboration aimed at advancing the development and commercialization of their respective autologous CAR-T cell therapies. Under the agreement, Autolus will receive a $50 million upfront payment, and BioNTech will make a $200 million equity investment in Autolus.03 Overview of Global Digital Health M&AKKR Acquires 50% Stake in Cotiviti for $11 BillionOn February 14, healthcare payment technology company Cotiviti announced that KKR and Veritas Capital would become co-sponsors of the company, each holding equal equity in Cotiviti. On the same day, KKR stated it had agreed to acquire 50% of Cotiviti's shares from Veritas. The transaction is expected to be completed in the second quarter of 2024. According to The Wall Street Journal, the deal values Cotiviti at approximately $11 billion, positioning it among the largest private equity transactions in recent times.Gilead Acquires Cymabay Therapeutics for $4.3 BillionOn February 12, Gilead announced that it had reached a definitive agreement with CymaBay Therapeutics to acquire CymaBay for $32.5 per share in cash, with a total equity value of approximately $4.3 billion. This acquisition will further expand Gilead's portfolio of products in the liver disease field. CymaBay’s lead product candidate is seladelpar, a PPARδ agonist for the treatment of primary biliary cholangitis (PBC). Currently, the FDA has accepted the product’s application for review and granted it priority review.ArteryNet/Arterial Orange Industry Think Tank/Huaxing Capital/BGI Co-Win/Rock Health/Mobile Health News/FierceHealth, etc.
Compiled by: Zhang Qiankun
